メタ情報
| meta description平均長 | 99.63 |
|---|
| OGPありページ数 | 80 |
|---|
| Twitterカードありページ数 | 7 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 573 |
|---|
| ページあたり内部リンク平均 | 133.99 |
|---|
内部リンク 深さヒストグラム
| キー | 値 |
|---|
| 0 | 16 |
| 1 | 253 |
| 2 | 1575 |
| 3 | 4509 |
| 4 | 3140 |
| 5 | 830 |
| 6 | 270 |
| 7 | 96 |
| 8 | 28 |
| 9 | 2 |
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| Ono | 1 |
| drug | 0.913652 |
| our | 0.891091 |
| agreement | 0.828916 |
| will | 0.719419 |
| entered | 0.695257 |
| new | 0.664474 |
| research | 0.662548 |
| Director | 0.651416 |
| clinical | 0.624606 |
| develop | 0.571438 |
| into | 0.544812 |
| collaboration | 0.540825 |
| commercialize | 0.539179 |
| Japan | 0.510732 |
| cancer | 0.499863 |
| Agreement | 0.490345 |
| was | 0.485215 |
| patients | 0.483698 |
| 6月 | 0.482423 |
| discovery | 0.47103 |
| human | 0.465274 |
| 4月 | 0.454045 |
| study | 0.44888 |
| has | 0.43934 |
| development | 0.432314 |
| growth | 0.425926 |
| Executive | 0.422961 |
| Member | 0.411479 |
| April | 0.40817 |
| treatment | 0.398053 |
| novel | 0.39729 |
| Inc | 0.3922 |
| Board | 0.387761 |
| company | 0.385513 |
| which | 0.383035 |
| have | 0.377859 |
| Officer | 0.377557 |
| June | 0.367465 |
| therapeutic | 0.361921 |
| cells | 0.361439 |
| exclusive | 0.354723 |
| platform | 0.354723 |
| animal | 0.350246 |
| drugs | 0.34598 |
| candidates | 0.342411 |
| antibody | 0.33674 |
| Deciphera | 0.330679 |
| through | 0.327351 |
| Business | 0.326896 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| discovery | drug | 3.966019 | 336 |
| commercialize | develop | 3.962297 | 146 |
| Board | Member | 3.96043 | 110 |
| Korea | South | 3.909852 | 72 |
| entered | into | 3.719416 | 192 |
| Executive | Officer | 3.629831 | 120 |
| Bristol | Myers | 3.626173 | 48 |
| Myers | Squibb | 3.626173 | 48 |
| Agreement | License | 3.583256 | 96 |
| FAX | TEL | 3.557814 | 48 |
| Audit | Supervisory | 3.494748 | 52 |
| Pharma | Specialty | 3.286051 | 52 |
| medium | term | 3.257975 | 59 |
| long | term | 3.242893 | 68 |
| Korea | Taiwan | 3.209493 | 48 |
| agreement | license | 3.197871 | 100 |
| Director | Executive | 3.197563 | 134 |
| around | world | 3.1949 | 60 |
| LTD | PHARMACEUTICAL | 3.188459 | 54 |
| Bristol | Squibb | 3.150205 | 38 |
| States | United | 3.139076 | 28 |
| Animal | Care | 3.126951 | 32 |
| Board | Directors | 3.091745 | 64 |
| molecule | small | 3.07805 | 36 |
| been | has | 3.067636 | 118 |
| billion | yen | 3.04615 | 27 |
| Corporate | Officer | 3.019855 | 85 |
| clinical | studies | 3.014296 | 112 |
| central | nervous | 3.012743 | 32 |
| polycythemia | vera | 3.005705 | 24 |
| not | only | 2.976997 | 72 |
| Care | Use | 2.971031 | 32 |
| innovation | open | 2.971031 | 32 |
| medical | needs | 2.964993 | 66 |
| Global | Specialty | 2.95086 | 52 |
| Board | Supervisory | 2.945561 | 52 |
| Accreditation | Laboratory | 2.932075 | 24 |
| clinical | trial | 2.92354 | 90 |
| President | Vice | 2.912123 | 37 |
| Director | Senior | 2.89868 | 83 |
| Data | Study | 2.84821 | 20 |
| genetically | modified | 2.84821 | 20 |
| Medicines | Targeted | 2.84821 | 20 |
| nervous | system | 2.833549 | 40 |
| Corporation | lwatani | 2.806855 | 36 |
| approval | received | 2.784226 | 36 |
| concurrent | holding | 2.76801 | 20 |
| ONO | PHARMACEUTICAL | 2.757139 | 100 |
| Ono | entered | 2.741187 | 173 |
| Animal | Laboratory | 2.738403 | 24 |
被リンク情報
このデータの閲覧には会員登録が必要になります。会員登録